Years of further research.13 May 2024 14:21
Even if there were to be a positive Phase II clinical trial of which there is not guaranteed, any authorisation could be received is at least until 2028. All you need is a few delays or set back and it is 2030. So this money they will now take, will not last long and they will then be wanting to issue more shares? This is an unprofitable company with zero earnings. It has some speculative unproven unauthorised method of injecting tumours. If it does not work which it has yet to prove or be given authority to use, it is the end. This is going down the rout of dilution.
VOTE NO. NO RTO